[an error occurred while processing this directive]
Genetic Resource

Diagnosis, treatment and genetic analysis of a case with fibrocalculous pancreatic diabetes

Expand
  • 1. Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
    2. Department of Endocrinology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China

Received date: 2022-06-21

  Revised date: 2022-09-01

  Online published: 2022-09-07

Supported by

the National Natural Science Foundation of China(81900708);Postgraduate Research & Practice Innovation Program of Jiangsu Province(JX10213850);Sinocare Diabetes Foundation(2021SD02)

Abstract

Fibrocalculous pancreatic diabetes (FCPD) is a rare type of diabetes mellitus with both impaired endocrine and exocrine functions of the pancreas. In this report, we presented a case with FCPD, who had recurrent abdominal pain since early childhood and was diagnosed with diabetes mellitus at the age of 25, with pancreatic calcification on abdominal computed tomography (CT) scan. Genetic testing revealed two homozygous mutations in the SPINK1 gene (c.194+2T>C and -191-24G>A). Both the homozygous variants were shared by his unaffected sibling, and the heterozygous variants had been verified on their unaffected parents. Based on this case and 90 other reported cases in China, we retrospectively analyzed the clinical characteristics of FCPD. It is recommended that unclassified diabetic patients with a lean body type, no ketosis tendency but poor islet function should be considered for the possibility of FCPD. Pancreatic imaging and genetic testing may be beneficial for the differential diagnosis. This study improves our understanding and management of FCPD, and also enriches clinical evidence for subsequent research on pathogenic mechanisms and drug target screening.

Cite this article

Min Shen, Yong Gu, Changjiang Ying, Mei Zhang, Tao Yang, Yang Chen . Diagnosis, treatment and genetic analysis of a case with fibrocalculous pancreatic diabetes[J]. Hereditas(Beijing), 2022 , 44(11) : 1079 -1086 . DOI: 10.16288/j.yczz.22-210

References

[1] Bhat JA, Bhat MH, Misgar RA, Bashir MI, Wani AI, Masoodi SR, Ashraf H, Sood M. The clinical spectrum of fibrocalculous pancreatic diabetes in kashmir valley and comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus. Indian J Endocrinol Metab, 2019, 23(5): 580-584.
[2] Feng SS, Wang S. Diagnosis and treatment of a case of fibrocalculous pancreatic diabetes. Shangdong Med J, 2021, 61(21): 84-87.
[2] 冯姗姗, 王肃. 1例胰腺纤维钙化性糖尿病的诊断及治疗. 山东医药, 2021, 61(21): 84-87.
[3] Chi HY, Wang AH, Liu YJ, Zhou YP. Fibrocalculous pancreatic diabetes: one case report and literature review. Chin J Endocrinol Metab, 2014, (8): 701-704.
[3] 迟海燕, 王爱红, 刘彦君, 周玉萍. 胰腺纤维钙化性糖尿病一例并文献复习. 中华内分泌代谢杂志, 2014, (8): 701-704.
[4] Yang SL, Chen M, Li N, Xu L, Luo YL, Zhang MN, Bu L, Lin ZW, Li H, Qu S. Fibrocalculous pancreatic diabetes: one case report and literature review. Int J Endocrinol Metab, 2017, 37 (5): 355-357.
[4] 杨绍玲, 陈铭, 李楠, 徐璐, 罗伊丽, 张曼娜, 卜乐, 林紫薇, 李鸿, 曲伸. 胰腺纤维钙化性糖尿病1例并文献复习. 国际内分泌代谢杂志, 2017, 37(5): 355-357.
[5] Pan JX, Jiang F, Sun MY, Lin F. Fibrocalculous pancreatic diabetes: one case report and literature review. Chin J Diabetes, 2017, 25(6): 563-564.
[5] 潘金兴, 姜锋, 孙铭遥, 林帆. 胰腺纤维钙化性糖尿病一例报告及文献复习. 中国糖尿病杂志, 2017, 25(6): 563-564.
[6] Cha XY, Wei CS, Lai PB. Analysis of clinical characteristics of 16 cases with fibrocalculous pancreatic diabetes and literature review. Fujian Med J, 2020, 42(4): 14-17.
[6] 查小云, 魏长顺, 赖鹏斌. 胰腺纤维钙化性糖尿病16例临床特点分析并文献复习. 福建医药杂志, 2020, 42(4): 14-17.
[7] Liu XM, Ouyang LL, Xian Su, Wang WQ. Two cases of calcareous pancreatitis of family resulted diabetes mellitus. J Clin Intern Med, 2001, 18(3): 236.
[7] 刘晓梅, 欧阳玲莉, 冼苏, 王文清. 家族性钙化性胰腺炎致糖尿病二例. 临床内科杂志, 2001, 18(3): 236.
[8] Chen YL, Chen GF, Liu C. Fibrocalculous pancreatic diabetes: a case report and literature review. Chin J Endocrinol Metab, 2021, 37(2): 165-167.
[8] 陈彦乐, 陈国芳, 刘超. 胰腺纤维钙化性糖尿病一例并文献复习. 中华内分泌代谢杂志, 2021, 37(2): 165-167.
[9] Li YR, Yu ZQ, Pan HL, Hong Y. Clinical and laboratory study on tropical pancreatic diabetes. J Guangxi Med Univ, 1998, 15(2): 11-13.
[9] 黎英荣, 于志清, 潘海林, 洪英. 热带胰腺性糖尿病的临床特点及实验室研究. 广西医科大学学报, 1998, 15(2): 11-13.
[10] Wang J, Tian HM, Liang JZ. Pancreaticolithiasis and fibrocalcific diabetes mellitus. West China Med J, 1995, 10(4): 403-404.
[10] 王静, 田浩明, 梁荩忠. 胰石症与胰腺纤维钙化性糖尿病. 华西医学, 1995, 10(4): 403-404.
[11] Jia Q, Zhang Y, Ma KN. Fibrocalcuous pancreatic diabetes:8 cases report. J Liaoning Pract Diabetes, 2001, 9(3): 39-40.
[11] 贾奇, 张音, 马克宁. 胰腺纤维化结石性糖尿病(附8例报告). 辽宁实用糖尿病杂志, 2001, 9(3): 39-40.
[12] Li YJ, Su HY. Fibrocalculous pancreatic diabetes: one case report. Chin J Diabetes, 2014, 22(12): 1136-1137.
[12] 李勇杰, 苏宏业. 胰腺纤维钙化性糖尿病一例报告. 中国糖尿病杂志, 2014, 22(12): 1136-1137.
[13] Shi Y. Pancreatic fibrotic calculous diabetes mellitus: a case report and literature review. J Hepatobiliary Surg, 2003, 11(6): 449-451.
[13] 施勇. 胰腺纤维化结石性糖尿病(附1例报告并文献复习). 肝胆外科杂志, 2003, 11(6): 449-451
[14] Chen JZ, Li J, Zhu KX. Fibrocalculous pancreatic diabetes misdiagnosed as type 1 diabetes for years: a case report and literature review. Acad J Chin PLA Med Sch, 2020, 41(7): 752-754.
[14] 陈炯镇, 李佳, 朱凯旋. 胰腺纤维钙化性糖尿病长期误诊为1型糖尿病1例报告并文献复习. 解放军医学院学报, 2020, 41(7): 752-754.
[15] Wang JW, Yu BJ, Chen P. Chen YT. Fibrocalcuous pancreatic diabetes: a case report. Chin J Rural Med Pharm, 2020, 27(16): 38-39.
[15] 王金委, 俞碧君, 陈平, 陈盈婷. 胰腺纤维钙化性糖尿病1例. 中国乡村医药, 2020, 27(16): 38-39.
[16] Li WG, Deng YH, Mai KY. Fibrocalcuous pancreatic diabetes complicated with osteoporosis: a case report. Guangdong Med J, 2020, 21(10): 844.
[16] 李万根, 邓煜辉, 麦坤仪. 胰腺纤维钙化性糖尿病并骨质疏松症1例. 广东医学, 2020, 21(10): 844.
[17] Liu B, Yu RP, Luo JH, Long BD. Fibrocalcuous pancreatic diabetes misdiagnosed as type 1 diabetes. Clin Misdiagn Misther, 2011, 24(10): 70-71.
[17] 刘波, 于瑞萍, 罗建华, 龙本丹. 胰腺纤维钙化性糖尿病误诊为1型糖尿病. 临床误诊误治, 2011, 24(10): 70-71.
[18] Wang YQ, Wu FX, Liang QF, Zhao YD, Wu JP. Fibrocalcuous pancreatic diabetes: a case report. Zhejiang J Integr Med, 2021, 31(2): 147-149.
[18] 王云卿, 吴飞翔, 梁秋芳, 赵延栋, 吴君平. 胰腺纤维钙化性糖尿病一例报道. 浙江中西医结合杂志, 2021, 31(2): 147-149.
[19] Deng YY, Zhang JL, Qiu L. Pancreatic fibrotic calculous diabetes mellitus: a case report and literature review. Clin Focus, 2015, 30(12): 1433-1434.
[19] 邓英英, 张晶露, 邱琳. 胰腺纤维钙化性糖尿病2例并文献复习. 临床荟萃, 2015, 30(12): 1433-1434.
[20] Ye SZ, Qian GX. Fibrocalculous pancreatic diabetes:10 cases report. Chin J Endocrinol Metab, 1991, 7(4): 198-200.
[20] 叶绍珍, 钱光相. 胰纤维化结石性糖尿病(附10例报告). 中华内分泌代谢杂志, 1991, 7(4): 198-200.
[21] Pei Y, Pang P, Wang HZ, Han XF, Wang XL, Du J, Yang GQ, Lv ZH, Mu YM, Lu JM, Dou JT. Three cases of fibrocalculous pancreatic diabetes and review of literatures. Chin J Diabetes Mellitus, 2012, 4(12): 713-717.
[21] 裴育, 庞萍, 王海珍, 韩晓菲, 王先令, 杜锦, 杨国庆, 吕朝晖, 母义明, 陆菊明, 窦京涛. 胰腺纤维钙化性糖尿病三例报告及文献复习. 中华糖尿病杂志, 2012, 4(12): 713-717.
[22] Papita R, Nazir A, Anbalagan VP, Anjana RM, Pitchumoni C, Chari S, Mohan V. Secular trends of fibrocalculous pancreatic diabetes and diabetes secondary to alcoholic chronic pancreatitis at a tertiary care diabetes centre in South India. JOP, 2012, 13(2): 205-209.
[23] Kolly A, Shivaprasad C, Pulikkal AA, Atluri S, Sarathi V, Dwarakanath CS. High prevalence of serine protease inhibitor Kazal type 1 gene variations detected by whole gene sequencing in patients with fibrocalculous Pancreatic Diabetes. Indian J Endocrinol Metab, 2017, 21(4): 510-514.
[24] Chowdhury ZM, McDermott MF, Davey S, Hassan Z, Sinnott PJ, Hemmatpour SK, Sherwin S, Ali L, Aganna E, Allotey RA, North BV, Cassell PG, Azad Khan AK, Hitman GA. Genetic susceptibility to fibrocalculous pancreatic diabetes in Bangladeshi subjects: a family study. Genes Immun, 2002, 3(1): 5-8.
[25] Mohan V, Nagalotimath SJ, Yajnik CS, Tripathy BB. Fibrocalculous pancreatic diabetes. Diabetes Metab Rev, 1998, 14(2): 153-170.
[26] Kibirige D, Kibudde S, Mutebi E. Fibrocalculous pancreatic diabetes in a young Ugandan patient, a rare form of secondary diabetes. BMC Res Notes, 2012, 5(1): 622-624.
[27] Li MH, Wang SH, Xu KF, Chen Y, Fu Q, Gu Y, Shi Y, Zhang M, Sun M, Chen H, Han XQ, Li YX, Tang ZK, Cai LJ, Li ZQ, Shi YY, Yang T, Polychronakos C. High prevalence of a monogenic cause in Han Chinese diagnosed with type 1 diabetes, partly driven by nonsyndromic recessive WFS1 mutations. Diabetes, 2020, 69(1): 121-126.
[28] Ghosh I, Mukhopadhyay P, Das K, Anne M B, Ali Mondal S, Basu M, Nargis T, Pandit K, Chakrabarti P, Ghosh S. Incretins in fibrocalculous pancreatic diabetes: a unique subtype of pancreatogenic diabetes. J Diabetes, 2021, 13(6): 506-511.
[29] Barman KK, Premalatha G, Mohan V. Tropical chronic pancreatitis. Postgrad Med J, 2003, 79(937): 606-615.
[30] Chari ST, Mohan V, Pitchumoni CS, Viswanathan M, Madanagopalan N, Lowenfels AB. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas, 1994, 9(1): 62-66.
Outlines

/